Results 291 to 300 of about 284,370 (314)

Testing for HER2 Status

Oncology, 2001
Incorporation of a new biological marker such as HER2 into routine clinical practice requires proof that it provides reproducible information independent of, and better than, conventional pathologic criteria, and that it influences treatment decisions.
openaire   +2 more sources

HER2-Positive (HER2 +) Breast Cancer

2022
Tinslee Dilday, Elizabeth Yeh
openaire   +1 more source

Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity

Cancer Cell, 2021
Ariella B Hanker, Benjamin P Brown, Jens Meiler   +2 more
exaly  

Targeting HER2-positive breast cancer: advances and future directions

Nature Reviews Drug Discovery, 2022
Sandra M Swain, Mythili Shastry, Erika Hamilton   +2 more
exaly  

HER2

European Journal of Cancer, 2000
M.J. Piccart, A. Di Leo, A. Hamilton
openaire   +1 more source

???????? ???????????????????? ???????????????????? ?? ?????????????? ?????????????? ?? ?????????????????????? ?????????????? HER2-?????????????????????? ???????? ???????????????? ????????????

2010
?????????????????? ???????????????????? ?????????????????????? ????????????????????, ???????????????? ?????????????? ???????????????????? ???????? ??? ???????????????????? ?????????????????? ?? ?????????????????????? ?????????????????????????? ?? ?????????????? ?? ?????????????????????? ?????????????? HER2-?????????????????????? ???????? ???????????????
openaire   +1 more source

Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond

Seminars in Cancer Biology, 2021
Caterina Marchiò, Laura Annaratone, Ana Marques   +2 more
exaly  

?????????? ?????????? ?????????????????? ????????????????????, ?????????????????????? ?????????????????? ?????????? ???????????????????? ????????????????, ???????????????? ?? ???????????? ?????? ?????????????? HER2-???????????????????????????? ???????? ???????????????? ????????????

2018
?? ?????????????? ???? ???????????????????????? ?? ?????????????????? ?????????? ?????????? ?????????????????? ???????????????????? ?????? ?????????????????????????? ????????????????????, ?????????? ???????????????? ?????????????? ???????????????????? ???? 30 ???? 90 ??????, ?????????? ???????????????? ?????????? ?????????????????????????? ?????????? ??
openaire   +1 more source

HER2 Testing

2013
Mary Falzon, Michael Gandy
openaire   +1 more source

Evolving standards of care and new challenges in the management of HER2‐positive breast cancer

Ca-A Cancer Journal for Clinicians, 2020
Grace M Choong, Grace D Cullen, Ciara C O'sullivan   +2 more
exaly